RSS feed (help and list of feeds)
Statement of Intent
- Statement of Intent 2011/12 - 2013/14 (32 pages, 701 KB) 07 Jul 2011
- Statement of Intent 2010/11- 2012/13 (31 pages, 531 KB) 05 Jul 2010
- Statement of Intent 2009/2010 (29 pages, 1396 KB) 22 Jul 2009
- Statement of Intent 2009 (34 pages, 2032 KB) 17 Jul 2008
- Statement of Intent 2008 (34 pages, 3021 KB) 16 Jul 2007
- Statement of Intent 2007 (30 pages, 166 KB) 27 Sep 2006
- Statement of Intent 2006 (43 pages, 1860 KB) 07 Oct 2005
- Statement of Intent 2005 (46 pages, 2136 KB) 31 Aug 2004
- Statement of Intent 2004 (34 pages, 130 KB) 05 Aug 2003
- Statement of Intent 2003 (27 pages, 103 KB) 18 Feb 2003
- Statement of Intent 2002 (21 pages, 91 KB) 26 Jul 2002
Page updated on 01 Sep 2011
Linked documents
Statement of Intent 2011/12 - 2013/14 (32 pages, 701 KB)
Pharmaceutical Management Agency Statement of Intent 2011/12 - 2013/14 TABLE OF CONTENTS PART 1 …..2 PHARMAC – our role and contribution to health outcomes …2 FITTING IT ALL TOGETHER: DELIVERING OUTPUTS TO ACHIEVE OUTCOMES …. 4 MAPPING OUR OUTPUTS TO…
Statement of Intent 2010/11- 2012/13 (31 pages, 531 KB)
Pharmaceutical Management Agency Statement of Intent 2010/11–2012/13 INTRODUCTION PHARMAC is well placed to meet the challenges of the current economic environment. PHARMAC has a strong track record of managing funding within budget and the skills we have used to establish…
Statement of Intent 2009/2010 (29 pages, 1396 KB)
Pharmaceutical Management Agency Statement of Intent 2009/10 TABLE OF CONTENTS OVERVIEW OF PHARMAC ….1 OUR CONTRIBUTION TO THE MEDICINES SYSTEM ….1 OUR FORM AND FUNCTIONS…..1 OUR WORKING ENVIRONMENT….2 KEY EXPECTATIONS OF PHARMAC…4 ENSURING A BALANCED APPROACH TO OUR WORK…..4 UNDERSTANDING…
Statement of Intent 2004 (34 pages, 130 KB)
Pharmaceutical Management Agency (PHARMAC) Statement of Intent 1 July 2003 to 30 June 2004 M9-1-1 #72320 -2TABLE OF CONTENTS PART 1 PHARMAC’S OBJECTIVES AND STRATEGIC PRIORITIES PHARMAC’S Statutory Functions Strategic Priorities PHARMAC’s aim in 2003/04 Key Activities PHARMAC’s Contribution to…
